24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
V-Wave
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:56
Israel’s war with Iran costs up to $550 million a day
21:33
JPMorgan: Israel’s economic outlook hinges on length of Iran war
20:39
Insider links surface in Ondas’ Indo acquisition
18:31
Full list of Israeli high-tech funding rounds in 2026
More stories
Buzz
Most popular
Daily
Weekly
1
Israel orders airborne laser system for fighter jets and helicopters
2
Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”
3
After Symantec exit, Javelin founders raise $20 million for new cyber bet Raven
4
Niv-AI raises $12 million Seed round to unlock stranded power in data centers
5
Oasis Security raises $120 million Series B to secure the rise of AI agents
More news
V-Wave
6 stories about V-Wave
J&J’s $1.7 billion bet on Israeli heart device falters after FDA panel vote
10.12.25
|
CTech
Advisors reject effectiveness of V-Wave’s implant, threatening the contingent value of last year’s acquisition.
Riding the V-Wave exit: Who are the big winners?
21.08.24
|
Meir Orbach
The pharmaceutical giant Johnson & Johnson announced on Tuesday the purchase of the Israeli medical device company for up to $1.7 billion. BRM is the largest shareholder in the company and is expected to receive at least $100 million. The second largest shareholder is Pontifax VC of Tomer Kariv and Ran Nussbaum. Other notable investors include Ilan Grinboim and Prof. Benad Goldwasser.
Johnson & Johnson to acquire Israeli medical device maker V-Wave for up to $1.7 billion
20.08.24
|
Meir Orbach
V-Wave's device is implanted in the heart through a minimally invasive procedure to help reduce heart failure and other events.
Israel-based V-Wave raises $98 million for heart failure beating shunt
23.09.20
|
Meir Orbach
Group of global healthcare investors backs the company as it gears up for clinical trials
These Ten Israeli Companies Raised the Most Money in 2018
03.07.18
|
Orr Hirschauge
CTech takes a look at the biggest funding rounds of the past six months
Israeli Medical Device Developer V-Wave Raises $70 Million
26.04.18
|
Meir Orbach
V-Wave develops a minimally invasive implanted shunt device for treating patients with severe heart failure